Evolent Health, Inc. – Consensus ‘buy’ rating and 43.6% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Evolent Health, Inc. with ticker code (EVH) now have 8 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 63 and 36 with the average target price sitting at $47.25. Given that the stocks previous close was at $32.90 this now indicates there is a potential upside of 43.6%. The day 50 moving average is $33.15 while the 200 day moving average is $32.10. The company has a market capitalization of 3.64B. The current share price for the company is: 32.33 USD

The potential market cap would be $5,231,331,391 based on the market consensus.

USD

The company has a dividend yield of 5.95%. Other points of data to note are a P/E ratio of -, revenue per share of 15.09 and a 0.38% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search